PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
17-Jun-2024 HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology HUTCHMED
17-Jun-2024 TALVEY®▼ (talquetamab) demonstrated highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma Johnson & Johnson
17-Jun-2024 Updated Phase 2 CAPTIVATE study results demonstrate sustained clinical benefit of fixed-duration IMBRUVICA® (ibrutinib) plus venetoclax as first-line treatment for patients with chronic lymphocytic leukaemia, including those with high-risk disease Johnson & Johnson
14-Jun-2024 NEW KITE CLINICAL RESEARCH AND REAL-WORLD EVIDENCE FOR YESCARTA® (AXICABTAGENE CILOLEUCEL) DEMONSTRATE BENEFIT FROM EARLIER LINES OF TREATMENT KITE
14-Jun-2024 Celltrion showcases promising results in phase III study for CT-P47, a biosimilar candidate of RoActemra® (tocilizumab) in patients with rheumatoid arthritis (RA) at EULAR 2024 Celltrion
13-Jun-2024 Resolution Therapeutics to Host Virtual R&D Webinar on Liver Disease with World Leading Hepatologist Arun Sanyal, M.D. Resolution Therapeutics
13-Jun-2024 Terminally sterilised plastic bottled media range launched to support sustainability initiatives Cherwell
13-Jun-2024 Xeltis receives IDE approval from FDA for initiation of US pivotal trial for aXessTM, its restorative vascular access conduit Xeltis
13-Jun-2024 Uppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnostics Uppsala University Hospital
13-Jun-2024 Leriglitazone halts disease progression in adult patients with early cerebral adrenoleukodystrophy in compassionate-use study published in Brain Minoryx Therapeutics
12-Jun-2024 CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT CluePoints
12-Jun-2024 BellaSeno Reports Positive Interim Findings of Australian Clinical Trials in Breast Scaffold Patients BellaSeno GmbH
11-Jun-2024 CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’ CluePoints
11-Jun-2024 EFFICIENT RECYCLING PROCESS FOR RARE EARTHS THROUGH BIOLEACHING AND BIOACCUMULATION BOKU Tulln and IMC University
11-Jun-2024 ChargePoint Technology launches new robotic solution to help transform the future of GMP manufacturing ChargePoint Technology
11-Jun-2024 Dengue fever research projects receive funding boost amid growing global concerns LifeArc
11-Jun-2024 SCOTTISH MEDICINES CONSORTIUM ACCEPTS TIRZEPATIDE (MOUNJARO ®▼) FOR OBESITY IN ELIGIBLE ADULTS SCOTTISH MEDICINES CONSORTIUM
11-Jun-2024 CRISM Therapeutics Corp to continue pioneering R&D at PHTA following listing on the London Stock Exchange CRISM Therapeutics Corp
11-Jun-2024 Discovery Park partners with Canterbury Christ Church University to open CoLab, a new coworking labspace for early stage life science businesses Discovery Park
11-Jun-2024 PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT THE 2024 ANNUAL CONGRESS OF THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH ANGLE presenting two posters highlighting the utility of CTC & ctDNA dual analysis and ANGLE’s DNA Damage Response assay ANGLE plc